- Report
- September 2026
- 191 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- February 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- October 2026
- 194 Pages
Global
From €5381EUR$5,850USD£4,584GBP
- Report
- August 2026
- 115 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- October 2025
- 160 Pages
Global
From €2907EUR$3,160USD£2,476GBP
€3633EUR$3,950USD£3,095GBP
- Report
- November 2025
- 150 Pages
Global
From €5473EUR$5,950USD£4,663GBP
- Report
- January 2026
- 180 Pages
Global
From €4139EUR$4,500USD£3,526GBP
- Report
- November 2025
- 180 Pages
Global
From €4139EUR$4,500USD£3,526GBP
- Report
- September 2026
- 187 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 187 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- February 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- February 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- October 2026
- 565 Pages
Global
From €5381EUR$5,850USD£4,584GBP
- Report
- October 2026
- 227 Pages
Global
From €5381EUR$5,850USD£4,584GBP
- Report
- October 2026
- 174 Pages
Global
From €5381EUR$5,850USD£4,584GBP
- Report
- November 2025
- 150 Pages
Middle East
From €5473EUR$5,950USD£4,663GBP
- Report
- March 2026
- 260 Pages
United States
From €4461EUR$4,850USD£3,801GBP
- Report
- February 2026
- 100 Pages
Japan
From €4414EUR$4,799USD£3,761GBP
- Report
- September 2024
- 188 Pages
Global
From €4414EUR$4,799USD£3,761GBP
- Report
- September 2025
- 494 Pages
Global
From €4553EUR$4,950USD£3,879GBP

The Immunofluorescence Assay (IFA) market is a segment of the In Vitro Diagnostics (IVD) industry. It is used to detect the presence of antigens or antibodies in a sample, such as a blood or tissue sample. This type of assay is used to diagnose a variety of diseases, including autoimmune diseases, infectious diseases, and cancer. It is a highly sensitive and specific method of diagnosis, and is often used in combination with other diagnostic tests.
IFA tests are typically performed in a laboratory setting, and require specialized equipment and reagents. The market is driven by the increasing prevalence of diseases, the growing demand for accurate and timely diagnosis, and the development of new technologies.
Some of the major players in the Immunofluorescence Assay market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Danaher Corporation, and Roche Diagnostics. Show Less Read more